Publication | Closed Access

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials

AllergyAdvanced Lung DiseasePulmonary MedicineVilanterol Versus VilanterolMedicineReplicate Double-blindInhaled Fluticasone FuroatePulmonary Disease